{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T12:58:15Z","timestamp":1782478695509,"version":"3.54.5"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T00:00:00Z","timestamp":1699228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T00:00:00Z","timestamp":1699228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P50CA244690"],"award-info":[{"award-number":["P50CA244690"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Implementation Sci"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Germline genetic testing is recommended by the National Comprehensive Cancer Network (NCCN) for individuals including, but not limited to, those with a personal history of ovarian cancer, young-onset (&lt;\u200950\u00a0years) breast cancer, and a family history of ovarian cancer or male breast cancer. Genetic testing is underused overall, and rates are consistently lower among Black and Hispanic populations. Behavioral economics-informed implementation strategies, or nudges, directed towards patients and clinicians may increase the use of this evidence-based clinical practice.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Patients meeting eligibility for germline genetic testing for breast and ovarian cancer will be identified using electronic phenotyping algorithms. A pragmatic cohort study will test three sequential strategies to promote genetic testing, two directed at patients and one directed at clinicians, deployed in the electronic health record (EHR) for patients in OB-GYN clinics across a diverse academic medical center. We will use rapid cycle approaches informed by relevant clinician and patient experiences, health equity, and behavioral economics to optimize and de-risk our strategies and methods before trial initiation. Step 1 will send patients messages through the health system patient portal. For non-responders, step 2 will reach out to patients via text message. For non-responders, Step 3 will contact patients\u2019 clinicians using a novel \u201cpend and send\u201d tool in the EHR. The primary implementation outcome is engagement with germline genetic testing for breast and ovarian cancer predisposition, defined as a scheduled genetic counseling appointment. Patient data collected through the EHR (e.g., race\/ethnicity, geocoded address) will be examined as moderators of the impact of the strategies.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>This study will be one of the first to sequentially examine the effects of patient- and clinician-directed strategies informed by behavioral economics on engagement with breast and ovarian cancer genetic testing. The pragmatic and sequential design will facilitate a large and diverse patient sample, allow for the assessment of incremental gains from different implementation strategies, and permit the assessment of moderators of strategy effectiveness. The findings may help determine the impact of low-cost, highly transportable implementation strategies that can be integrated into healthcare systems to improve the use of genomic medicine.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>ClinicalTrials.gov. NCT05721326. Registered February 10, 2023. <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.clinicaltrials.gov\/study\/NCT05721326\">https:\/\/www.clinicaltrials.gov\/study\/NCT05721326<\/jats:ext-link><\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13012-023-01308-w","type":"journal-article","created":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T16:02:33Z","timestamp":1699286553000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Protocol to evaluate sequential electronic health record-based strategies to increase genetic testing for breast and ovarian cancer risk across diverse patient populations in gynecology practices"],"prefix":"10.1186","volume":"18","author":[{"given":"Heather","family":"Symecko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Schnoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinad S.","family":"Beidas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin E.","family":"Bekelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Blumenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Marika","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leland","family":"Boisseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Doucette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacquelyn","family":"Powers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Cappadocia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle B.","family":"McKenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Richardville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Cuff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Offer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth G.","family":"Clement","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison M.","family":"Buttenheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Asch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharine A.","family":"Rendle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel C.","family":"Shelton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwadamilola M.","family":"Fayanju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Paul","family":"Wileyto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Plag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Ware","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence N.","family":"Shulman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine L.","family":"Nathanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Domchek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,6]]},"reference":[{"issue":"3","key":"1308_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"1308_CR2","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41571-021-00514-z","volume":"18","author":"I Soerjomataram","year":"2021","unstructured":"Soerjomataram I, Bray F. Planning for tomorrow: global cancer incidence and the role of prevention 2020\u20132070. Nat Rev Clin Oncol. 2021;18(10):663\u201372.","journal-title":"Nat Rev Clin Oncol"},{"key":"1308_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","volume":"66","author":"M Arnold","year":"2022","unstructured":"Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M, et al. Current and future burden of breast cancer: Global statistics for 2020 and 2040. Breast. 2022;66:15\u201323.","journal-title":"Breast"},{"issue":"1","key":"1308_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7\u201333.","journal-title":"CA Cancer J Clin"},{"key":"1308_CR5","unstructured":"Centers for Disease Control and Prevention. Cancer Statistics At a Glance 2019 [Available from: https:\/\/gis.cdc.gov\/Cancer\/USCS\/?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcancer%2Fdataviz%2Findex.htm#\/AtAGlance\/."},{"issue":"1","key":"1308_CR6","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13048-017-0355-y","volume":"10","author":"SK Srivastava","year":"2017","unstructured":"Srivastava SK, Ahmad A, Miree O, Patel GK, Singh S, Rocconi RP, et al. Racial health disparities in ovarian cancer: not just black and white. J Ovarian Res. 2017;10(1):58.","journal-title":"J Ovarian Res"},{"issue":"2","key":"1308_CR7","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.ygyno.2013.12.039","volume":"133","author":"Y Collins","year":"2014","unstructured":"Collins Y, Holcomb K, Chapman-Davis E, Khabele D, Farley JH. Gynecologic cancer disparities: a report from the health disparities taskforce of the society of gynecologic oncology. Gynecol Oncol. 2014;133(2):353\u201361.","journal-title":"Gynecol Oncol"},{"issue":"10290","key":"1308_CR8","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1016\/S0140-6736(21)00731-5","volume":"397","author":"U Menon","year":"2021","unstructured":"Menon U, Gentry-Maharaj A, Burnell M, Singh N, Ryan A, Karpinskyj C, et al. Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial. Lancet. 2021;397(10290):2182\u201393.","journal-title":"Lancet"},{"key":"1308_CR9","unstructured":"Cancer Research UK. Ovarian cancer survival 2021 [Available from: https:\/\/www.cancerresearchuk.org\/about-cancer\/ovarian-cancer\/survival."},{"issue":"8","key":"1308_CR10","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1007\/s10552-010-9547-0","volume":"21","author":"CR Morris","year":"2010","unstructured":"Morris CR, Sands MT, Smith LH. Ovarian cancer: predictors of early-stage diagnosis. Cancer Causes Control. 2010;21(8):1203\u201311.","journal-title":"Cancer Causes Control"},{"issue":"3","key":"1308_CR11","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s12609-020-00364-1","volume":"12","author":"S Reid","year":"2020","unstructured":"Reid S, Cadiz S, Pal T. Disparities in genetic testing and care among Black women with hereditary breast cancer. Curr Breast Cancer Rep. 2020;12(3):125\u201331.","journal-title":"Curr Breast Cancer Rep"},{"issue":"25","key":"1308_CR12","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1056\/NEJMp2200244","volume":"386","author":"I Jatoi","year":"2022","unstructured":"Jatoi I, Sung H, Jemal A. The emergence of the racial disparity in U.S. breast-cancer mortality. N Engl J Med. 2022;386(25):2349\u201352.","journal-title":"N Engl J Med"},{"issue":"27","key":"1308_CR13","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1200\/JCO.19.00363","volume":"37","author":"SM Domchek","year":"2019","unstructured":"Domchek SM, Robson ME. Update on genetic testing in gynecologic cancer. J Clin Oncol. 2019;37(27):2501\u20139.","journal-title":"J Clin Oncol"},{"issue":"1","key":"1308_CR14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.6004\/jnccn.2021.0001","volume":"19","author":"MB Daly","year":"2021","unstructured":"Daly MB, Pal T, Berry MP, Buys SS, Dickson P, Domchek SM, et al. Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021;19(1):77\u2013102.","journal-title":"J Natl Compr Canc Netw"},{"issue":"5","key":"1308_CR15","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1056\/NEJMoa2005936","volume":"384","author":"C Hu","year":"2021","unstructured":"Hu C, Hart SN, Gnanaolivu R, Huang H, Lee KY, Na J, et al. A population-based study of genes previously implicated in breast cancer. N Engl J Med. 2021;384(5):440\u201351.","journal-title":"N Engl J Med"},{"issue":"9","key":"1308_CR16","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1001\/jama.2010.1237","volume":"304","author":"SM Domchek","year":"2010","unstructured":"Domchek SM, Friebel TM, Singer CF, Evans DG, Lynch HT, Isaacs C, et al. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA. 2010;304(9):967\u201375.","journal-title":"JAMA"},{"issue":"12","key":"1308_CR17","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.annonc.2022.09.159","volume":"33","author":"CE Geyer Jr","year":"2022","unstructured":"Geyer CE Jr, Garber JE, Gelber RD, Yothers G, Taboada M, Ross L, et al. Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1\/2 and high-risk, early breast cancer. Ann Oncol. 2022;33(12):1250\u201368.","journal-title":"Ann Oncol"},{"issue":"25","key":"1308_CR18","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1056\/NEJMoa2105215","volume":"384","author":"ANJ Tutt","year":"2021","unstructured":"Tutt ANJ, Garber JE, Kaufman B, Viale G, Fumagalli D, Rastogi P, et al. Adjuvant Olaparib for patients with BRCA1- or BRCA2-mutated breast cancer. N Engl J Med. 2021;384(25):2394\u2013405.","journal-title":"N Engl J Med"},{"issue":"4","key":"1308_CR19","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/tbj.13007","volume":"24","author":"S Yadav","year":"2018","unstructured":"Yadav S, Jinna S, Pereira-Rodrigues O, Reeves A, Campian S, Sufka A, et al. Impact of preoperative BRCA1\/2 testing on surgical decision making in patients with newly diagnosed breast cancer. Breast J. 2018;24(4):541\u20138.","journal-title":"Breast J"},{"issue":"1","key":"1308_CR20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/jso.23712","volume":"111","author":"MJ Hall","year":"2015","unstructured":"Hall MJ, Forman AD, Montgomery SV, Rainey KL, Daly MB. Understanding patient and provider perceptions and expectations of genomic medicine. J Surg Oncol. 2015;111(1):9\u201317.","journal-title":"J Surg Oncol"},{"issue":"6","key":"1308_CR21","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.pec.2020.12.024","volume":"104","author":"M Smith-Uffen","year":"2021","unstructured":"Smith-Uffen M, Bartley N, Davies G, Best M. Motivations and barriers to pursue cancer genomic testing: a systematic review. Patient Educ Couns. 2021;104(6):1325\u201334.","journal-title":"Patient Educ Couns"},{"issue":"6","key":"1308_CR22","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.mcna.2019.08.004","volume":"103","author":"PR Heck","year":"2019","unstructured":"Heck PR, Meyer MN. Population whole exome screening: primary care provider attitudes about preparedness, information avoidance, and nudging. Med Clin North Am. 2019;103(6):1077\u201392.","journal-title":"Med Clin North Am"},{"key":"1308_CR23","first-page":"PO.19.00338","volume":"4","author":"JS de Moor","year":"2020","unstructured":"de Moor JS, Gray SW, Mitchell SA, Klabunde CN, Freedman AN. Oncologist confidence in genomic testing and implications for using multimarker tumor panel tests in practice. JCO Precis Oncol. 2020;4:PO.19.00338.","journal-title":"JCO Precis Oncol"},{"issue":"6","key":"1308_CR24","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1002\/cncr.34053","volume":"128","author":"CM McBride","year":"2022","unstructured":"McBride CM, Pathak S, Johnson CE, Alberg AJ, Bandera EV, Barnholtz-Sloan JS, et al. Psychosocial factors associated with genetic testing status among African American women with ovarian cancer: results from the African American cancer epidemiology study. Cancer. 2022;128(6):1252\u20139.","journal-title":"Cancer"},{"issue":"4","key":"1308_CR25","doi-asserted-by":"publisher","first-page":"351","DOI":"10.6004\/jnccn.2022.7257","volume":"21","author":"KS Lau-Min","year":"2023","unstructured":"Lau-Min KS, McCarthy AM, Nathanson KL, Domchek SM. Nationwide trends and determinants of germline BRCA1\/2 testing in patients with breast and ovarian cancer. J Natl Compr Canc Netw. 2023;21(4):351-8 e4.","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"1308_CR26","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ygyno.2018.07.023","volume":"151","author":"J Lee","year":"2018","unstructured":"Lee J, Gubernick LR, Brodsky AL, Fehniger JE, Levine DA, Gerber D, et al. Missed opportunities: genetic counseling and testing among an ethnically diverse cohort of women with endometrial cancer. Gynecol Oncol. 2018;151(1):153\u20138.","journal-title":"Gynecol Oncol"},{"issue":"15","key":"1308_CR27","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1200\/JCO.18.01854","volume":"37","author":"AW Kurian","year":"2019","unstructured":"Kurian AW, Ward KC, Howlader N, Deapen D, Hamilton AS, Mariotto A, et al. Genetic testing and results in a population-based cohort of breast cancer patients and ovarian cancer patients. J Clin Oncol. 2019;37(15):1305\u201315.","journal-title":"J Clin Oncol"},{"issue":"22","key":"1308_CR28","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1200\/JCO.2015.66.0019","volume":"34","author":"AM McCarthy","year":"2016","unstructured":"McCarthy AM, Bristol M, Domchek SM, Groeneveld PW, Kim Y, Motanya UN, et al. Health care segregation, physician recommendation, and racial disparities in BRCA1\/2 testing among women with breast cancer. J Clin Oncol. 2016;34(22):2610\u20138.","journal-title":"J Clin Oncol"},{"issue":"5","key":"1308_CR29","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1377\/hlthaff.2017.1427","volume":"37","author":"KA Phillips","year":"2018","unstructured":"Phillips KA, Deverka PA, Hooker GW, Douglas MP. Genetic test availability and spending: where are we now? Where are we going? Health Aff (Millwood). 2018;37(5):710\u20136.","journal-title":"Health Aff (Millwood)"},{"issue":"9","key":"1308_CR30","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1038\/s41436-020-0903-5","volume":"22","author":"N Dragojlovic","year":"2020","unstructured":"Dragojlovic N, Borle K, Kopac N, Ellis U, Birch P, Adam S, et al. Correction: the composition and capacity of the clinical genetics workforce in high-income countries: a scoping review. Genet Med. 2020;22(9):1570.","journal-title":"Genet Med"},{"key":"1308_CR31","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.3389\/fgene.2019.01059","volume":"10","author":"MS Williams","year":"2019","unstructured":"Williams MS, Taylor CO, Walton NA, Goehringer SR, Aronson S, Freimuth RR, et al. Genomic information for clinicians in the electronic health record: lessons learned from the clinical genome resource project and the electronic medical records and genomics network. Front Genet. 2019;10:1059.","journal-title":"Front Genet"},{"issue":"10","key":"1308_CR32","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/gim.2013.131","volume":"15","author":"AN Kho","year":"2013","unstructured":"Kho AN, Rasmussen LV, Connolly JJ, Peissig PL, Starren J, Hakonarson H, et al. Practical challenges in integrating genomic data into the electronic health record. Genet Med. 2013;15(10):772\u20138.","journal-title":"Genet Med"},{"issue":"7","key":"1308_CR33","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1038\/s41436-018-0378-9","volume":"21","author":"AM Zebrowski","year":"2019","unstructured":"Zebrowski AM, Ellis DE, Barg FK, Sperber NR, Bernhardt BA, Denny JC, et al. Qualitative study of system-level factors related to genomic implementation. Genet Med. 2019;21(7):1534\u201340.","journal-title":"Genet Med"},{"key":"1308_CR34","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1016\/j.gim.2022.08.009","volume":"24","author":"KS Lau-Min","year":"2022","unstructured":"Lau-Min KS, McKenna D, Asher SB, Bardakjian T, Wollack C, Bleznuck J, et al. Impact of integrating genomic data into the electronic health record on genetics care delivery. Genet Med. 2022;24:2338.","journal-title":"Genet Med"},{"issue":"237\u201343","key":"1308_CR35","volume":"237","author":"LS Franck","year":"2021","unstructured":"Franck LS, Kriz RM, Rego S, Garman K, Hobbs C, Dimmock D. Implementing rapid whole-genome sequencing in critical care: a qualitative study of facilitators and barriers to new technology adoption. J Pediatr. 2021;237(237\u201343): e2.","journal-title":"J Pediatr"},{"issue":"3","key":"1308_CR36","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/jpm8030024","volume":"8","author":"A Owusu Obeng","year":"2018","unstructured":"Owusu Obeng A, Fei K, Levy KD, Elsey AR, Pollin TI, Ramirez AH, et al. Physician-reported benefits and barriers to clinical implementation of genomic medicine: a multi-site IGNITE-network survey. J Pers Med. 2018;8(3):24.","journal-title":"J Pers Med"},{"issue":"2","key":"1308_CR37","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.ekir.2020.10.030","volume":"6","author":"K Jayasinghe","year":"2021","unstructured":"Jayasinghe K, Quinlan C, Mallett AJ, Kerr PG, McClaren B, Nisselle A, et al. Attitudes and practices of Australian nephrologists toward implementation of clinical genomics. Kidney Int Rep. 2021;6(2):272\u201383.","journal-title":"Kidney Int Rep"},{"key":"1308_CR38","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/1472-6963-13-279","volume":"13","author":"WC Birmingham","year":"2013","unstructured":"Birmingham WC, Agarwal N, Kohlmann W, Aspinwall LG, Wang M, Bishoff J, et al. Patient and provider attitudes toward genomic testing for prostate cancer susceptibility: a mixed method study. BMC Health Serv Res. 2013;13:279.","journal-title":"BMC Health Serv Res"},{"key":"1308_CR39","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1002\/jgc4.1579","volume":"31","author":"YQ Lee","year":"2022","unstructured":"Lee YQ, Yoon SY, Hassan T, Padmanabhan H, Yip CH, Keng WT, et al. Attitudes and training needs of oncologists and surgeons in mainstreaming breast cancer genetic counseling in a low-to-middle income Asian country. J Genet Couns. 2022;31:1080.","journal-title":"J Genet Couns"},{"key":"1308_CR40","first-page":"PO.20.00418","volume":"5","author":"KS Lau-Min","year":"2021","unstructured":"Lau-Min KS, Guerra CE, Nathanson KL, Bekelman JE. From race-based to precision oncology: leveraging behavioral economics and the electronic health record to advance health equity in cancer care. JCO Precis Oncol. 2021;5:PO.20.00418.","journal-title":"JCO Precis Oncol"},{"issue":"7","key":"1308_CR41","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.22092","volume":"5","author":"R Kukafka","year":"2022","unstructured":"Kukafka R, Pan S, Silverman T, Zhang T, Chung WK, Terry MB, et al. Patient and clinician decision support to increase genetic counseling for hereditary breast and ovarian cancer syndrome in primary care: a cluster randomized clinical trial. JAMA Netw Open. 2022;5(7): e2222092.","journal-title":"JAMA Netw Open"},{"issue":"4157","key":"1308_CR42","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1126\/science.185.4157.1124","volume":"185","author":"A Tversky","year":"1974","unstructured":"Tversky A, Kahneman D. Judgment under uncertainty: heuristics and biases. Science. 1974;185(4157):1124\u201331.","journal-title":"Science"},{"issue":"Suppl 1","key":"1308_CR43","doi-asserted-by":"publisher","first-page":"187","DOI":"10.18865\/ed.29.S1.187","volume":"29","author":"MC Roberts","year":"2019","unstructured":"Roberts MC, Mensah GA, Khoury MJ. Leveraging implementation science to address health disparities in genomic medicine: examples from the field. Ethn Dis. 2019;29(Suppl 1):187\u201392.","journal-title":"Ethn Dis"},{"issue":"6","key":"1308_CR44","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1200\/JOP.2012.000626","volume":"8","author":"SW Gray","year":"2012","unstructured":"Gray SW, Hicks-Courant K, Lathan CS, Garraway L, Park ER, Weeks JC. Attitudes of patients with cancer about personalized medicine and somatic genetic testing. J Oncol Pract. 2012;8(6):329\u201335 p following 35.","journal-title":"J Oncol Pract"},{"issue":"9","key":"1308_CR45","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1097\/GIM.0b013e3181ab22aa","volume":"11","author":"S Suther","year":"2009","unstructured":"Suther S, Kiros GE. Barriers to the use of genetic testing: a study of racial and ethnic disparities. Genet Med. 2009;11(9):655\u201362.","journal-title":"Genet Med"},{"issue":"12","key":"1308_CR46","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1158\/1055-9965.EPI-17-0389","volume":"26","author":"LE Steffen","year":"2017","unstructured":"Steffen LE, Du R, Gammon A, Mandelblatt JS, Kohlmann WK, Lee JH, et al. Genetic testing in a population-based sample of breast and ovarian cancer survivors from the REACH randomized trial: cost barriers and moderators of counseling mode. Cancer Epidemiol Biomarkers Prev. 2017;26(12):1772\u201380.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"1308_CR47","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1089\/gtmb.2018.0253","volume":"23","author":"D Cragun","year":"2019","unstructured":"Cragun D, Weidner A, Kechik J, Pal T. Genetic testing across young Hispanic and non-hispanic white breast cancer survivors: facilitators, barriers, and awareness of the genetic information nondiscrimination act. Genet Test Mol Biomarkers. 2019;23(2):75\u201383.","journal-title":"Genet Test Mol Biomarkers"},{"issue":"3","key":"1308_CR48","first-page":"267","volume":"22","author":"BA Glenn","year":"2012","unstructured":"Glenn BA, Chawla N, Bastani R. Barriers to genetic testing for breast cancer risk among ethnic minority women: an exploratory study. Ethn Dis. 2012;22(3):267\u201373.","journal-title":"Ethn Dis"},{"issue":"1","key":"1308_CR49","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1186\/s12889-017-4375-8","volume":"17","author":"KEJ Hann","year":"2017","unstructured":"Hann KEJ, Freeman M, Fraser L, Waller J, Sanderson SC, Rahman B, et al. Awareness, knowledge, perceptions, and attitudes towards genetic testing for cancer risk among ethnic minority groups: a systematic review. BMC Public Health. 2017;17(1):503.","journal-title":"BMC Public Health"},{"issue":"e2","key":"1308_CR50","doi-asserted-by":"publisher","first-page":"e320","DOI":"10.1136\/amiajnl-2013-002579","volume":"21","author":"D Rogith","year":"2014","unstructured":"Rogith D, Yusuf RA, Hovick SR, Peterson SK, Burton-Chase AM, Li Y, et al. Attitudes regarding privacy of genomic information in personalized cancer therapy. J Am Med Inform Assoc. 2014;21(e2):e320\u20135.","journal-title":"J Am Med Inform Assoc"},{"issue":"1","key":"1308_CR51","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/0022-1031(91)90011-T","volume":"27","author":"M Spranca","year":"1991","unstructured":"Spranca M, Minsk E, Baron J. Omission and commission in judgment and choice. J Exp Soc Psychol. 1991;27(1):76\u2013105.","journal-title":"J Exp Soc Psychol"},{"issue":"1","key":"1308_CR52","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s10897-015-9851-7","volume":"25","author":"JL Schneider","year":"2016","unstructured":"Schneider JL, Goddard KA, Davis J, Wilfond B, Kauffman TL, Reiss JA, et al. \u201cIs it worth knowing?\u201d Focus group participants\u2019 perceived utility of genomic preconception carrier screening. J Genet Couns. 2016;25(1):135\u201345.","journal-title":"J Genet Couns"},{"issue":"4","key":"1308_CR53","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1007\/s12160-014-9679-7","volume":"49","author":"JM Taber","year":"2015","unstructured":"Taber JM, Klein WM, Ferrer RA, Lewis KL, Harris PR, Shepperd JA, et al. Information avoidance tendencies, threat management resources, and interest in genetic sequencing feedback. Ann Behav Med. 2015;49(4):616\u201321.","journal-title":"Ann Behav Med"},{"issue":"13","key":"1308_CR54","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1002\/cncr.30621","volume":"123","author":"D Cragun","year":"2017","unstructured":"Cragun D, Weidner A, Lewis C, Bonner D, Kim J, Vadaparampil ST, et al. Racial disparities in BRCA testing and cancer risk management across a population-based sample of young breast cancer survivors. Cancer. 2017;123(13):2497\u2013505.","journal-title":"Cancer"},{"issue":"5","key":"1308_CR55","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1001\/jama.2016.16918","volume":"317","author":"AW Kurian","year":"2017","unstructured":"Kurian AW, Griffith KA, Hamilton AS, Ward KC, Morrow M, Katz SJ, et al. Genetic testing and counseling among patients with newly diagnosed breast cancer. JAMA. 2017;317(5):531\u20134.","journal-title":"JAMA"},{"issue":"2","key":"1308_CR56","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s10549-022-06523-5","volume":"195","author":"DT Linfield","year":"2022","unstructured":"Linfield DT, Rothberg MB, Pfoh ER, Noss R, Cassard L, Powers JC, et al. Primary care physician referral practices regarding BRCA1\/2 genetic counseling in a major health system. Breast Cancer Res Treat. 2022;195(2):153\u201360.","journal-title":"Breast Cancer Res Treat"},{"issue":"44","key":"1308_CR57","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1093\/jncimonographs\/lgs006","volume":"2012","author":"KC Stange","year":"2012","unstructured":"Stange KC, Breslau ES, Dietrich AJ, Glasgow RE. State-of-the-art and future directions in multilevel interventions across the cancer control continuum. J Natl Cancer Inst Monogr. 2012;2012(44):20\u201331.","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"13","key":"1308_CR58","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1056\/NEJMsb071595","volume":"357","author":"SD Halpern","year":"2007","unstructured":"Halpern SD, Ubel PA, Asch DA. Harnessing the power of default options to improve health care. N Engl J Med. 2007;357(13):1340\u20134.","journal-title":"N Engl J Med"},{"issue":"11","key":"1308_CR59","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1007\/s11606-012-2050-4","volume":"27","author":"MS Patel","year":"2012","unstructured":"Patel MS, Volpp KG. Leveraging insights from behavioral economics to increase the value of health-care service provision. J Gen Intern Med. 2012;27(11):1544\u20137.","journal-title":"J Gen Intern Med"},{"issue":"3","key":"1308_CR60","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1056\/NEJMp1712984","volume":"378","author":"MS Patel","year":"2018","unstructured":"Patel MS, Volpp KG, Asch DA. Nudge units to improve the delivery of health care. N Engl J Med. 2018;378(3):214\u20136.","journal-title":"N Engl J Med"},{"issue":"1","key":"1308_CR61","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13012-020-01011-0","volume":"15","author":"SL Yoong","year":"2020","unstructured":"Yoong SL, Hall A, Stacey F, Grady A, Sutherland R, Wyse R, et al. Nudge strategies to improve healthcare providers\u2019 implementation of evidence-based guidelines, policies and practices: a systematic review of trials included within cochrane systematic reviews. Implement Sci. 2020;15(1):50.","journal-title":"Implement Sci"},{"issue":"7","key":"1308_CR62","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-048801","volume":"11","author":"BS Last","year":"2021","unstructured":"Last BS, Buttenheim AM, Timon CE, Mitra N, Beidas RS. Systematic review of clinician-directed nudges in healthcare contexts. BMJ Open. 2021;11(7): e048801.","journal-title":"BMJ Open"},{"issue":"9","key":"1308_CR63","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1001\/jamapsychiatry.2021.1120","volume":"78","author":"RS Beidas","year":"2021","unstructured":"Beidas RS, Buttenheim AM, Mandell DS. Transforming mental health care delivery through implementation science and behavioral economics. JAMA Psychiat. 2021;78(9):941\u20132.","journal-title":"JAMA Psychiat"},{"issue":"7","key":"1308_CR64","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1001\/jamaoncol.2020.0746","volume":"6","author":"SU Takvorian","year":"2020","unstructured":"Takvorian SU, Ladage VP, Wileyto EP, Mace DS, Beidas RS, Shulman LN, et al. Association of behavioral nudges with high-value evidence-based prescribing in oncology. JAMA Oncol. 2020;6(7):1104\u20136.","journal-title":"JAMA Oncol"},{"issue":"6","key":"1308_CR65","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1001\/jama.2016.0275","volume":"315","author":"D Meeker","year":"2016","unstructured":"Meeker D, Linder JA, Fox CR, Friedberg MW, Persell SD, Goldstein NJ, et al. Effect of behavioral interventions on inappropriate antibiotic prescribing among primary care practices: a randomized clinical trial. JAMA. 2016;315(6):562\u201370.","journal-title":"JAMA"},{"issue":"1","key":"1308_CR66","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jaccao.2020.02.006","volume":"2","author":"KJ Waddell","year":"2020","unstructured":"Waddell KJ, Shah PD, Adusumalli S, Patel MS. Using behavioral economics and technology to improve outcomes in cardio-oncology. JACC CardioOncol. 2020;2(1):84\u201396.","journal-title":"JACC CardioOncol"},{"issue":"11","key":"1308_CR67","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1093\/tbm\/ibab105","volume":"11","author":"KA Rendle","year":"2021","unstructured":"Rendle KA, Beidas RS. Four strategic areas to advance equitable implementation of evidence-based practices in cancer care. Transl Behav Med. 2021;11(11):1980\u20138.","journal-title":"Transl Behav Med"},{"key":"1308_CR68","unstructured":"Pew Research Center. Mobile Fact Sheet 2021 [updated April 7, 2021. Available from: https:\/\/www.pewresearch.org\/internet\/fact-sheet\/mobile\/."},{"issue":"2","key":"1308_CR69","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/jamia\/ocac227","volume":"30","author":"C Richwine","year":"2023","unstructured":"Richwine C, Johnson C, Patel V. Disparities in patient portal access and the role of providers in encouraging access and use. J Am Med Inform Assoc. 2023;30(2):308\u201317.","journal-title":"J Am Med Inform Assoc"},{"issue":"1","key":"1308_CR70","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12874-017-0393-6","volume":"17","author":"P Mistry","year":"2017","unstructured":"Mistry P, Dunn JA, Marshall A. A literature review of applied adaptive design methodology within the field of oncology in randomised controlled trials and a proposed extension to the CONSORT guidelines. BMC Med Res Methodol. 2017;17(1):108.","journal-title":"BMC Med Res Methodol"},{"issue":"12","key":"1308_CR71","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.3390\/jpm12121974","volume":"12","author":"A Verma","year":"2022","unstructured":"Verma A, Damrauer SM, Naseer N, Weaver J, Kripke CM, Guare L, et al. The penn medicine biobank: towards a genomics-enabled learning healthcare system to accelerate precision medicine in a diverse population. J Pers Med. 2022;12(12):1974.","journal-title":"J Pers Med"},{"issue":"1","key":"1308_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/NEJMp1203869","volume":"367","author":"DA Asch","year":"2012","unstructured":"Asch DA, Muller RW, Volpp KG. Automated hovering in health care\u2013watching over the 5000 hours. N Engl J Med. 2012;367(1):1\u20133.","journal-title":"N Engl J Med"},{"issue":"9","key":"1308_CR73","first-page":"1","volume":"17","author":"DA Asch","year":"2012","unstructured":"Asch DA, Volpp KG. On the way to health. LDI Issue Brief. 2012;17(9):1\u20134.","journal-title":"LDI Issue Brief"},{"issue":"1","key":"1308_CR74","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13012-021-01156-6","volume":"16","author":"SU Takvorian","year":"2021","unstructured":"Takvorian SU, Bekelman J, Beidas RS, Schnoll R, Clifton ABW, Salam T, et al. Behavioral economic implementation strategies to improve serious illness communication between clinicians and high-risk patients with cancer: protocol for a cluster randomized pragmatic trial. Implement Sci. 2021;16(1):90.","journal-title":"Implement Sci"},{"key":"1308_CR75","doi-asserted-by":"publisher","first-page":"4511","DOI":"10.1200\/JCO.23.00355","volume":"41","author":"BP Jenssen","year":"2023","unstructured":"Jenssen BP, Schnoll R, Beidas RS, Bekelman J, Bauer AM, Evers-Casey S, et al. Cluster randomized pragmatic clinical trial testing behavioral economic implementation strategies to improve tobacco treatment for patients with cancer who smoke. J Clin Oncol. 2023;41:4511 JCO2300355.","journal-title":"J Clin Oncol"},{"issue":"7","key":"1308_CR76","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1056\/NEJMp1506311","volume":"373","author":"DA Asch","year":"2015","unstructured":"Asch DA, Rosin R. Innovation as discipline, not fad. N Engl J Med. 2015;373(7):592\u20134.","journal-title":"N Engl J Med"},{"issue":"1","key":"1308_CR77","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s12875-021-01550-5","volume":"22","author":"BS Last","year":"2021","unstructured":"Last BS, Buttenheim AM, Futterer AC, Livesey C, Jaeger J, Stewart RE, et al. A pilot study of participatory and rapid implementation approaches to increase depression screening in primary care. BMC Fam Pract. 2021;22(1):228.","journal-title":"BMC Fam Pract"},{"key":"1308_CR78","unstructured":"Lee KC, Al-Ramahi N, Hahn L, Donnell T, Schonewolf L, Khan N, et al. Operationalizing equity: a rapid-cycle innovation approach to Covid-19 vaccination in black neighborhoods. NEJM Catalyst Innov Care Deliv 2021;2(2)."},{"issue":"7831","key":"1308_CR79","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/s41586-020-2817-4","volume":"586","author":"ED Green","year":"2020","unstructured":"Green ED, Gunter C, Biesecker LG, Di Francesco V, Easter CL, Feingold EA, et al. Strategic vision for improving human health at The forefront of genomics. Nature. 2020;586(7831):683\u201392.","journal-title":"Nature"},{"issue":"8","key":"1308_CR80","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1097\/MPH.0000000000001592","volume":"41","author":"EM Stevens","year":"2019","unstructured":"Stevens EM, Patterson CA, Tchume-Johnson T, Antiel RM, Flake A, Smith-Whitley K, et al. Parental attitudes towards prenatal genetic testing for sickle cell disease. J Pediatr Hematol Oncol. 2019;41(8):579\u201385.","journal-title":"J Pediatr Hematol Oncol"}],"container-title":["Implementation Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13012-023-01308-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13012-023-01308-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13012-023-01308-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T16:03:00Z","timestamp":1699286580000},"score":1,"resource":{"primary":{"URL":"https:\/\/implementationscience.biomedcentral.com\/articles\/10.1186\/s13012-023-01308-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,6]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1308"],"URL":"https:\/\/doi.org\/10.1186\/s13012-023-01308-w","relation":{},"ISSN":["1748-5908"],"issn-type":[{"value":"1748-5908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,6]]},"assertion":[{"value":"29 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This trial was approved by the University of Pennsylvania Institutional Review Board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"RSB is the principal at Implementation Science & Practice, LLC. She receives royalties from Oxford University Press, consulting fees from United Behavioral Health and OptumLabs, and serves on the advisory boards for Optum Behavioral Health, AIM Youth Mental Health Foundation, and the Klingenstein Third Generation Foundation outside of the submitted work. JEB reports grants from AstraZeneca, Emerson Collective, Loxo@Lilly, and Gilead and personal fees from Reimagine Care, Healthcare Foundry, and AstraZeneca, outside the submitted work. DBM reports having been a one-time consultant for Nest Genomics. DAA is a partner at VAL Health. KAR reports receiving grants from Pfizer and AstraZeneca paid to her institution, personal fees from Merck for serving as a scientific consultant, and honoraria and travel paid as an invited speaker from MJH Life Sciences outside the submitted work. KLN reports serving on a Scientific Advisory Board for Merck, unrelated to the current study. SMD reports consulting fees from AstraZeneca and GlaxoSmithKline.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"57"}}